Follow the Money: Knowns and unknowns when it comes to cash transfers and financial incentives to improve health in people living with and/or at risk of HIV

This webinar featured Wafaa El-Sadr, principal investigator of HPTN 065, which evaluated the use of cash incentives in improving outcomes for people living with HIV in the United States.

These were useful talks from CROI and excerpts from AVAC Report 2014/15 as preparation for our webinar:

CROI Webcast: Effect of Financial Incentives on Linkage to Care and Viral Suppression: HPTN 065
CROI Webcast: Social Protection, Financial Incentives and Prevention of HIV
Excerpts from AVAC Report on target setting and targets that worked

Oral Pre-Exposure Prophylaxis – Putting a new choice in context

The World Health Organization (WHO) released updated guidance in late 2015 on oral pre-exposure prophylaxis (PrEP), containing tenofovir (TDF), as an additional HIV prevention choice. The new guidance is significantly broader than previously and creates real opportunities to move forward with implementing PrEP as part of comprehensive HIV programmes.

This publication, produced collaboratively between UNAIDS, WHO and AVAC, is intended to complement WHO recommendations and support the optimal use of oral PrEP to protect individuals and contribute to ending the AIDS epidemic.

AVAC Report 2014/15: HIV Prevention on the Line

In AVAC Report 2014/15: HIV Prevention on the Line, we take on the current state of global targets for the AIDS response, looking beyond pithy slogans to explore what’s in place and what’s not in terms of targets, resources and action to begin to end the AIDS epidemic. We also provide concise updates and calls to action on key prevention interventions including AIDS vaccines, voluntary medical male circumcision, microbicides, PrEP, and hormonal contraception use and HIV risk.

Intervention Update: Hormonal Contraception and HIV

Excerpted from AVAC Report: HIV Prevention on the Line, this update describes recent discussion and analysis in the search for answers as to whether hormonal contraceptives, including long-acting methods such as Depo-Provera (DPMA) and other injectable contraceptives and the implant, affect women’s risk of acquiring HIV.

Intervention Update: Voluntary Medical Male Circumcision

Excerpted from AVAC Report: HIV Prevention on the Line, this update cites the success of a previous VMMC target and suggests the current lack of a target moving forward will stifle continued progress.

Intervention Update: What’s Next for AIDS Vaccines and the P5 Partnership?

Excerpted from AVAC Report: HIV Prevention on the Line, this update details attempts to test vaccine strategy which showed promise in the RV144 trial.

Turning Targets into Impact

This graphic, which appears in the AVAC Report 2014/15, lists and describes key attributes that ensure a target into impact.

Mind the Gap

This graphic, presented in the AVAC Report 2014/15: HIV Prevention on the Line, shows all the components of a comprehensive response to end the epidemic.

Targets that Require Work: PrEP and Combination Prevention

Targets are urgently needed for daily oral PrEP and combination prevention. This graphic, from AVAC Report 2014/15: HIV Prevention on the Line, proposes goals and shows what’s in place and what is missing today.

Past Success, Present Gaps: VMMC targets, 2011 and today

VMMC (VMMC) is a highly effective HIV prevention strategy that has benefited from ambitious target setting that ticked all the boxes—investment, political will and evidence. This graphic is from AVAC Report 2014/15: HIV Prevention on the Line.